InvestorsHub Logo

Honeycomb777

04/19/19 10:24 AM

#19996 RE: Drugdoctor #19995

DD, respectfully, you are missing the point. This approval of the original ANDA makes INNV much more valuable because of the terms. Worldwide rights alone scream revenue taken away from gsk and others. You can’t just say so what.... another billion $$ market just opened up overseas. Ho hum, dude - We instantly became much more valuable as a takeover target. Watch when CBD oil comes next. Better cover

Batermere

04/20/19 7:48 AM

#20022 RE: Drugdoctor #19995

DUH, It most certainly is in the past if it was something you found in print before Thursday. Particularly the part about the charts being a “disaster”. LOL. Charts from even yesterday are old news and are IN THE PAST. What happens from here going forward is called “THE FUTURE”. They are not that difficult to differentiate. Regardless, we’ll see you at $30/share. Oops, probably not. I doubt you will still be here by then.